[Clinical Features and Prognosis of Patients with Diffuse Large B-Cell Lymphoma of the Breast].
Breast DLBCL is divided into two categories: PB-DLBCL and SB-DLBCL. Compared with SB-DLBCL, PB-DLBCL has the characteristics of lower IPI score, LDH, and β<sub>2</sub>-microglobulin levels. PB-DLBCL patients have a longer survival period. In addition, the prognosis of patients receiving central preventive treatment is more optimistic.
Authors
- Lie-Yang Wang
- Jia Wei (ORCID: https://orcid.org/0000-0002-6435-9368)
- Zhiqiang Zhao
- Liping Su (ORCID: https://orcid.org/0009-0006-6238-1234)
Institutions
- Shanxi Medical University (CN)
- Shanxi Provincial Cancer Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-10-01
- DOI
- https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.05.016
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article